보고서 요약(국문)

시장 개요
전 세계 기관지내 초음파 생검 시장은 2022년 5억 7,670만 달러에 달했으며, 2030년까지 8억 3,270만 달러에 이르러 높은 성장세를 보일 것으로 예상됩니다. 이 시장은 예측 기간(2023~2030년) 동안 연평균 4.8%의 성장률을 기록할 것으로 전망됩니다. 말초 폐 병변 진단에는 방사형 프로브 기관지내 초음파 생검(RP-endobronchial ultrasound biopsy)과 가이드 쉬스(GS) 기반 생검 방법이 자주 사용됩니다.
최근에는 폐 질환의 정확한 진단을 돕기 위해 냉동 생검, 전자기 유도 기관지경 검사, 초박형 기관지경 검사 등이 개발되었습니다. 종격동 림프절 샘플링인 종격동경 검사는 기관지내 초음파 생검(TBNA)보다 침습성이 낮으며, 폐문 림프절 샘플링에도 사용할 수 있고 가벼운 진정 하에 외래 환자 시술로 시행할 수 있습니다.

기관지내 초음파 생검 시장은 지난 몇 년간 기술이 급격히 발전하여 더욱 정밀하고 신속한 결과를 제공하는 새로운 도구와 방법이 개발되었습니다. 이러한 발전 덕분에 기관지내 초음파 생검은 이제 폐암 및 기타 호흡기 질환 진단에 가장 적합한 방법으로 자리 잡았습니다. 초음파 생검은 방사선을 사용하지 않고 통증이 없기 때문에 높은 성장세를 보일 것으로 예상됩니다.
기관지내 초음파 생검 시장의 높은 성장률은 여러 요인에 기인합니다. 그중 하나는 최소 침습 시술에 대한 수요 증가입니다. 최소 침습 시술은 개복 수술에 비해 통증이 적고 회복이 빠르며 합병증 발생률이 낮다는 장점이 있습니다. 기관지내 초음파 생검은 환자와 의료진 모두에게 선호되는 최소 침습 기술입니다. 환자의 치료 결과를 개선하고 사망률을 낮추기 위해서는 폐암을 조기에 발견하는 것이 매우 중요합니다.

시장 동향
폐암 발병률 증가와 연구 개발 투자 확대가 기관지내 초음파 생검 시장 성장을 견인하고 있습니다.

폐암 발병률 증가로 인해 기관지내 초음파 생검의 세계 시장이 확대되고 있습니다. 2022년 폐암 현황 보고서에 따르면, 폐암 환자의 26%만이 조기에 발견되지만, 조기 발견 시 5년 생존율은 61%로 상당히 높습니다. 하지만 44%의 환자는 너무 늦게 발견되어 생존율은 단 7%에 불과합니다. 폐암 발병의 최대 90%는 흡연과 관련이 있으며, 장기간의 흡연은 전 세계적으로, 특히 중국, 러시아, 인도와 같은 개발도상국에서 폐암 발병률을 더욱 증가시킬 것으로 예상됩니다.
주요 업체들은 기관지 흡인 바늘과 같은 기술적으로 진보된 제품 개발을 위한 연구 개발에 박차를 가하고 있습니다. 이는 폐 관련 감염이나 암을 정확하게 진단하기 위한 진단 도구에 대한 수요 증가에 따른 것입니다. 여러 기업들이 현재 진단 목적의 초음파 생검 제품 개발에 많은 투자와 노력을 기울이고 있습니다.
의료 분야에 대한 투자 증가는 제조업체들에게 수익성 있는 성장 전망을 제공하고 있습니다.

기관지내 초음파 생검은 호흡기 질환 진단에 널리 사용되고 있으며, 전반적인 폐 감염 유병률이 증가하고 있어 상당한 시장 기회가 있습니다. 진단에 필요한 기관지경유 흡인 바늘이나 생검 겸자와 같은 제품에 대한 수요가 증가함에 따라 제조업체는 수익성 있는 성장 기회를 얻을 수 있을 것입니다.
폐 질환의 정확한 진단을 돕기 위해 냉동 생검, 초박형 기관지경, 전자기 유도 기관지경과 같은 새로운 기술이 최근 개발되었습니다. 기관지내 초음파 생검(TBNA)은 폐문 림프절 채취에도 사용될 수 있으며, 가벼운 진정 하에 외래 시술로 시행할 수 있지만, 종격동 내부에서 시행하는 종격동경 검사보다 침습적입니다. 따라서 의료 인프라 투자 증가가 시장 성장에 기여하고 있습니다.
기관지내 초음파 생검의 높은 비용
기관지내 초음파 생검은 비용이 많이 들 수 있으며, 가격은 지역, 의료기관, 보험 적용 여부에 따라 달라질 수 있습니다. 일부 상황에서, 특히 의료비 지출이 적은 개발도상국에서는 기관지 내시경 초음파 생검 비용이 과도하게 느껴질 수 있습니다.
기관지 내시경 초음파 생검 시술 비용은 사용되는 도구, 시술 자체, 필요한 사후 관리 등 여러 항목으로 구성됩니다. 건강 보험 및 국가에 따라 보험에서 치료 비용의 전부 또는 일부를 부담하는 경우도 있습니다.
COVID-19 영향 분석
COVID-19 분석에는 COVID-19 이전 시나리오, COVID-19 시나리오, COVID-19 이후 시나리오와 함께 가격 변동(팬데믹 기간 및 이후의 가격 변화를 COVID-19 이전 시나리오와 비교), 수요-공급 양상(거래 제한, 봉쇄 및 그로 인한 문제로 인한 수요와 공급의 변화), 정부 정책(정부 기관의 시장, 부문 또는 산업 활성화 정책), 제조업체의 전략적 이니셔티브(제조업체가 COVID-19 문제를 완화하기 위해 취한 조치)가 포함됩니다.

러시아-우크라이나 분쟁 분석
러시아는 우크라이나에 대한 불법적이고 도발 없는 전면적인 침공을 시작했으며, 이로 인해 미국, 유엔 및 기타 국가로부터 제재를 받았습니다. 현재의 위기 상황으로 인해 많은 기업들이 러시아에서 사업을 중단하기 시작했습니다. 이러한 제재는 기업들이 러시아 시장에서 철수함에 따라 세계 시장에 상당한 영향을 미칠 것입니다. 악화되는 재정적 제약으로 인해 러시아-우크라이나 전쟁은 러시아의 의료기기 산업에 악영향을 미칠 것입니다.
세분화 분석
전 세계 기관지내 초음파 생검 시장은 제품 유형, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
폐암 진단 부문은 폐암 발병률 증가로 인해 시장 점유율의 63.7%를 차지하며 가장 큰 비중을 차지합니다.
폐암 환자 수 증가로 인해 폐암 진단 부문은 예측 기간 동안 전 세계 기관지내 초음파 생검 시장을 주도할 것입니다. 폐암, 감염, 그리고 흉부의 림프절 비대를 유발하는 기타 질환은 모두 최소 침습적이지만 매우 효율적인 방법인 기관지내 초음파(EBUS)를 통해 진단할 수 있습니다.
EBUS를 이용하면 의사는 기관지경유 바늘 흡인(TBNA)이라는 방법을 사용하여 기존의 수술 없이 폐와 인접한 림프절에서 조직이나 체액 샘플을 채취할 수 있습니다. 이러한 샘플은 림프종과 같은 종양을 식별하고, 폐암을 진단 및 병기 결정하고, 감염을 찾아내고, 유육종증과 같이 폐를 손상시키는 염증성 질환을 진단하는 데 사용될 수 있습니다.
예를 들어, 올림푸스는 업계 최고 수준인 21G, 22G, 25G 바늘 외에도 19G EBUS-TBNA 바늘을 제공합니다. 이 회사는 림프종 및 사르코이드증 의심 사례의 조직학적 샘플링을 지원하는 2세대 EBUS 바늘인 ViziShot2 FLEX 19G를 제공하며, 최첨단 분자 분석을 통해 표적 폐암 치료를 가능하게 하는 데 필요한 조직을 더 많이 공급합니다.
지역 분석
북미는 주요 업체들의 강력한 입지와 증가하는 의료 인프라 투자에 힘입어 시장 점유율 39.8%를 차지하고 있습니다.
북미 지역에서 폐 감염 진단 도구에 대한 수요가 증가함에 따라 제조업체들은 사업 확장의 기회를 얻고 있습니다. 이 지역에는 많은 생산자와 공급업체가 있으며, 빠른 경제 발전으로 기관지내 초음파 생검의 산업 생산이 증가하여 수요가 증가했습니다.
또한 첨단 생검 도구를 장려하는 정부 정책도 성장을 촉진하고 있습니다. 폐암 환자 수가 급증하면서 최첨단 진단 및 치료 도구에 대한 수요가 증가하고 있는 것도 중요한 요인입니다. 의료 전문가들이 기관지내 초음파 생검 도구에 대한 충분한 지식을 갖추고 있으며, 폐 관련 질환 진단에 이 도구를 적극적으로 활용하고 있기 때문에 이 지역의 시장은 성장하고 있습니다.

경쟁 환경
기관지내 초음파 생검 시장의 주요 글로벌 업체로는 Olympus Corporation, CLINODEVICE, Medtronic, CONMED Corporation, Boston Scientific Corporation, Medi-Globe GmbH, Serpex Medical, MICRO-TECH (Nanjing) Co., Ltd., Cook Group Incorporated, ACE Medical Devices Pvt. Ltd. 등이 있습니다.
보고서 구매 이유

• 제품 유형, 적용 분야, 최종 사용자 및 지역별 글로벌 기관지내 초음파 생검 시장 세분화를 시각화하고 주요 기업 및 주요 업체를 파악합니다.

• 시장 동향 및 공동 개발 분석을 통해 사업 기회를 발굴합니다.

• 모든 세그먼트를 포함한 기관지내 초음파 생검 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품 목록이 담긴 Excel 파일 형태의 제품 맵핑을 제공합니다.

글로벌 기관지내 초음파 생검 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
The global endobronchial ultrasound biopsy market reached US$ 576.7 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 832.7 million by 2030. The market is growing at a CAGR of 4.8% during the forecast period (2023-2030). To diagnose peripheral pulmonary lesions, radial probe endobronchial ultrasound biopsy (RP-endobronchial ultrasound biopsy ) and guide sheath (GS)-based biopsy methods are utilized frequently.
Cryo biopsy, electromagnetic navigational bronchoscopy, and ultrathin bronchoscopy have recently been developed to aid in the precise diagnosis of lung illnesses. The mediastinal LN sampling, mediastinoscopy, is less invasive than endobronchial ultrasound biopsy -TBNA, which can also be used to sample hilar lymph nodes and can be done as an outpatient procedure with light sedation.
In the endobronchial ultrasound biopsy market, over the past few years, technology has advanced drastically, with new tools and methods being created that give more precision and quicker outcomes. Because of these developments, endobronchial ultrasound biopsy is now the method of choice for identifying lung cancer and other respiratory conditions. The ultrasound biopsy market will see high growth as it doesn’t use radiation and is painless.
The endobronchial ultrasound biopsy market growth rate is high owing to various factors such as increasing demand for minimally invasive procedures because they have a number of advantages over open surgeries, such as less pain, quicker recovery, and fewer complications. Endobronchial ultrasound biopsy trend is seen as it is a less invasive technique which makes it desirable for both patients and healthcare professionals. To improve patient outcomes and lower mortality rates, lung cancer must be detected early.
Market Dynamics
The increasing prevalence of lung cancer and research and development drives the growth of the endobronchial ultrasound biopsy market.
The global market for endobronchial ultrasound biopsy is expanding as a result of the rising prevalence of lung cancer. Only 26% of lung cancer cases are identified at an early stage, despite the fact that the five-year survival rate is substantially higher (61%), according to the State of Lung Cancer 2022 Report. However, 44% of cases are discovered far too late, when just 7% of them survive. Up to 90% of occurrences of lung cancer are attributable to tobacco use, and prolonged usage is expected to increase the incidence of cancer worldwide, especially in developing countries like China, Russia, and India.
Key players are expanding their research and development efforts for technologically advanced products such as transbronchial aspiration needles. This is happening as a result of the rising demand for diagnostic tools for proper detection of lung related infections or cancer. Several firms are currently investing and putting a lot of effort in developing better ultrasound biopsy products for diagnostic purposes.
The growing investments in healthcare create lucrative growth prospects for manufacturers.
There is a sizable market opportunity for endobronchial ultrasound biopsy as it is becoming more widely accepted for the diagnosis of respiratory disorders and because the overall prevalence of lung infections is rising. Manufacturers are going to have profitable choices for growth as demand for products like transbronchial aspiration needles or biopsy forceps for diagnosis will be required.
To assist in the accurate detection of lung diseases, new technologies such as cryo biopsy, ultrathin bronchoscopy, and electromagnetic navigational bronchoscopy were just recently created. The endobronchial ultrasonography biopsy, or TBNA, which may be utilized as well for sampling hilar lymph nodes & can be performed as an outpatient operation with mild sedation, is more intrusive than mediastinoscopy, which takes place inside the mediastinum. Hence, rising investments or healthcare infrastructure spending are contributing to the growth of the market.
High cost of an endobronchial ultrasound biopsy
An endobronchial ultrasound biopsy can be expensive, and the price can change depending on the area, the medical center, and insurance coverage. In some circumstances, patients may find the expense of an endobronchial ultrasound biopsy to be exorbitant, especially in underdeveloped nations where healthcare spending is minimal.
The price of an endobronchial ultrasound biopsy procedure can be broken down into a number of different costs, including those for the tools used, the treatment itself, and any required aftercare. Depending on the health plan and the nation, insurance may occasionally pay all or part of the cost of the treatment.
COVID-19 Impact Analysis
The COVID-19 analysis includes Pre-COVID Scenario, COVID Scenario and Post-COVID Scenario along with pricing dynamics (including pricing change during and post-pandemic comparing it with pre-COVID scenarios), demand-supply spectrum (shift in demand and supply owing to trading restrictions, lockdown and subsequent issues), government initiatives (initiatives to revive market, sector or industry by government bodies) and manufacturers strategic initiatives (what manufacturers did to mitigate the COVID issues will be covered here).
Russia Ukraine Conflict Analysis
Russia started its unlawful and unprovoked full-scale invasion of Ukraine, which resulted in sanctions against Russia from the US, the UN, and other nations. In light of the current crisis, many businesses are starting to stop operating in Russia. These sanctions will surely have a significant effect on the worldwide market as businesses start to leave the Russian market. Due to worsening financial restrictions, the Russo-Ukrainian War will have a detrimental effect on the medical device industry in Russia.
Segment Analysis
The global endobronchial ultrasound biopsy market is segmented based on product type, application, End User and region.
Lung cancer diagnosis segment holds largest 63.7% of market share owing to the rising incidence of lung cancers
Lung cancer diagnosis segment will dominate the global endobronchial ultrasound biopsy market over the forecast period, owing to the rise in patients with lung cancer. Lung cancer, infections, and other disorders affecting enlarged lymph nodes in the chest can all be identified with endobronchial ultrasonography (EBUS), a minimally invasive but extremely efficient method.
EBUS enables doctors to use a method known as transbronchial needle aspiration (TBNA) to retrieve tissue or fluid samples from the lungs and adjacent lymph nodes without requiring traditional surgery. The samples can be used to identify tumours like lymphoma, diagnose and stage lung cancer, find infections, and diagnose inflammatory diseases that damage the lungs, such as sarcoidosis.
For instance, Olympus offers 19G EBUS-TBNA needles in addition to the 21G, 22G, and 25G needles, which is unmatched in the industry. The business also offers the ViziShot2 FLEX 19G, a second-generation EBUS needle that assists with histology sampling for suspected cases of lymphoma and sarcoidosis while also supplying more tissue for cutting-edge molecular analysis that enables targeted lung cancer treatment.
Geographical Analysis
North America holds 39.8% of market share owing to the strong presence of major players and increasing healthcare infrastructure investment.
Manufacturers have chances to expand their operations in this region because of the rising demand for diagnostic tools for lung infections in North America. The area has many producers and suppliers, and its rapid economic development has raised industrial production of endobronchial ultrasound biopsy, which has increased the demand.
Growth is also fueled by government measures to promote technologically advanced biopsy tools. Another issue is the rapidly expanding population with lung cancer, which has increased demand for cutting-edge, diagnostic and treatment tools. The region is growing as healthcare professionals have good knowledge about the endobronchial ultrasound biopsy tool, and they are adopting it highly for diagnosis of lung related issues among people.
Competitive Landscape
The major global players in the endobronchial ultrasound biopsy market include Olympus Corporation, CLINODEVICE, Medtronic, CONMED Corporation, Boston Scientific Corporation, Medi-Globe GmbH, Serpex Medical, MICRO-TECH (Nanjing) Co., Ltd., Cook Group Incorporated, and ACE Medical Devices Pvt. Ltd. among others.
Why Purchase the Report?
• To visualize the global endobronchial ultrasound biopsy market segmentation based on product type, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of endobronchial ultrasound biopsy market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The global endobronchial ultrasound biopsy market report would provide approximately 53 tables, 54 figures and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End User
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing benefits of endobronchial ultrasound biopsy devices
4.1.1.2. Increasing prevalence of lung cancer and research and development
4.1.2. Restraints
4.1.2.1. High cost of an endobronchial ultrasound biopsy
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Before COVID-19 Scenario
6.1.2. Present COVID-19 Scenario
6.1.3. Post COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Transbronchial Aspiration Needles *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Biopsy Needles
7.4. Biopsy Forceps
7.5. Other
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Lung Cancer Diagnosis *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Lung Infection Diagnosis
9. By End User
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostics Laboratories
9.4. Cancer Specialty Centers
9.5. Ambulatory Surgical Centers
9.6. Academic and Research centers
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. The U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. The U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
Australia
10.5.6.4. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Olympus Corporation *
12.1.1. Company Overview
12.1.2. Product Type Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Medtronic plc
12.3. CLINODEVICE
12.4. CONMED Corporation
12.5. Medi-Globe Corporation
12.6. Boston Scientific Corporation
12.7. Serpex Medical
12.8. Cook Group Incorporated
12.9. MICRO-TECH (Nanjing) Co., Ltd.
12.10. ACE Medical Devices Pvt. Ltd.
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Olympus Corporation, 4.	Key Developments, Medtronic plc, CLINODEVICE, CONMED Corporation, Medi-Globe Corporation, Boston Scientific Corporation, Serpex Medical, Cook Group Incorporated, MICRO-TECH (Nanjing) Co., Ltd., ACE Medical Devices Pvt. Ltd.

표 목록 (Tables)

List of Tables

Table 1 Global Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Endobronchial Ultrasound Biopsy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Endobronchial Ultrasound Biopsy Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Endobronchial Ultrasound Biopsy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 7 Global Endobronchial Ultrasound Biopsy Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 8 Global Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 9 Global Endobronchial Ultrasound Biopsy Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 10 Global Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 11 Global Endobronchial Ultrasound Biopsy Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 12 Global Endobronchial Ultrasound Biopsy Market Value, By Region, 2022-2031 (US$ Million)

Table 13 North America Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 14 North America Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 15 North America Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 16 North America Endobronchial Ultrasound Biopsy Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 18 South America Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 19 South America Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 20 South America Endobronchial Ultrasound Biopsy Market Value, By Country, 2022-2031 (US$ Million)

Table 21 Europe Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 Europe Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 23 Europe Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 24 Europe Endobronchial Ultrasound Biopsy Market Value, By Country, 2022-2031 (US$ Million)

Table 25 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 26 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, By Country, 2022-2031 (US$ Million)

Table 29 Middle East & Africa Endobronchial Ultrasound Biopsy Market Value, By Product Type, 2022-2031 (US$ Million)

Table 30 Middle East & Africa Endobronchial Ultrasound Biopsy Market Value, By Application, 2022-2031 (US$ Million)

Table 31 Middle East & Africa Endobronchial Ultrasound Biopsy Market Value, By End User, 2022-2031 (US$ Million)

Table 32 Olympus Corporation: Overview

Table 33 Olympus Corporation: Product Portfolio

Table 34 Olympus Corporation: Key Developments

Table 35 Medtronic: Overview

Table 36 Medtronic: Product Portfolio

Table 37 Medtronic: Key Developments

Table 38 CLINODEVICE: Overview

Table 39 CLINODEVICE: Product Portfolio

Table 40 CLINODEVICE: Key Developments

Table 41 CONMED Corporation: Overview

Table 42 CONMED Corporation: Product Portfolio

Table 43 CONMED Corporation: Key Developments

Table 44 Medi-Globe GmbH: Overview

Table 45 Medi-Globe GmbH: Product Portfolio

Table 46 Medi-Globe GmbH: Key Developments

Table 47 Boston Scientific Corporation: Overview

Table 48 Boston Scientific Corporation: Product Portfolio

Table 49 Boston Scientific Corporation: Key Developments

Table 50 Serpex Medical: Overview

Table 51 Serpex Medical: Product Portfolio

Table 52 Serpex Medical: Key Developments

Table 53 Cook Group Incorporated: Overview

Table 54 Cook Group Incorporated: Product Portfolio

Table 55 Cook Group Incorporated: Key Developments

Table 56 MICRO-TECH (Nanjing) Co., Ltd.: Overview

Table 57 MICRO-TECH (Nanjing) Co., Ltd.: Product Portfolio

Table 58 MICRO-TECH (Nanjing) Co., Ltd.: Key Developments

Table 59 ACE Medical Devices Pvt. Ltd.: Overview

Table 60 ACE Medical Devices Pvt. Ltd.: Product Portfolio

Table 61 ACE Medical Devices Pvt. Ltd.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 2 Global Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 4 Global Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 5 Global Endobronchial Ultrasound Biopsy Market Share, By Region, 2022 & 2031 (%)

Figure 6 Global Endobronchial Ultrasound Biopsy Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 7 Transbronchial Aspiration Needles Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 8 Biopsy Needles Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 9 Biopsy Forceps Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 10 Other Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 11 Global Endobronchial Ultrasound Biopsy Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 12 Lung Cancer Diagnosis Application in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 13 Lung Infection Diagnosis Application in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 14 Global Endobronchial Ultrasound Biopsy Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 15 Hospitals End User in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 16 Diagnostics Laboratories End User in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 17 Cancer Specialty Centers End User in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 18 Ambulatory Surgical Centers End User in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 19 Academic and Research centers End User in Global Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 20 Global Endobronchial Ultrasound Biopsy Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 21 North America Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 22 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 23 Europe Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 24 South America Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 25 Middle East and Africa Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 26 North America Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 27 North America Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 28 North America Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 29 North America Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 30 North America Endobronchial Ultrasound Biopsy Market Share, By Country, 2022 & 2031 (%)

Figure 31 South America Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 32 South America Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 33 South America Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 34 South America Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 35 South America Endobronchial Ultrasound Biopsy Market Share, By Country, 2022 & 2031 (%)

Figure 36 Europe Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 37 Europe Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 38 Europe Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 39 Europe Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 40 Europe Endobronchial Ultrasound Biopsy Market Share, By Country, 2022 & 2031 (%)

Figure 41 Asia-Pacific Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 42 Asia-Pacific Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 43 Asia-Pacific Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 44 Asia-Pacific Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 45 Asia-Pacific Endobronchial Ultrasound Biopsy Market Share, By Country, 2022 & 2031 (%)

Figure 46 Middle East & Africa Endobronchial Ultrasound Biopsy Market Value, 2022-2031 (US$ Million)

Figure 47 Middle East & Africa Endobronchial Ultrasound Biopsy Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Middle East & Africa Endobronchial Ultrasound Biopsy Market Share, By Application, 2022 & 2031 (%)

Figure 49 Middle East & Africa Endobronchial Ultrasound Biopsy Market Share, By End User, 2022 & 2031 (%)

Figure 50 Olympus Corporation: Financials

Figure 51 Medtronic: Financials

Figure 52 CLINODEVICE: Financials

Figure 53 CONMED Corporation: Financials

Figure 54 Medi-Globe GmbH: Financials

Figure 55 Boston Scientific Corporation: Financials

Figure 56 Serpex Medical: Financials

Figure 57 Cook Group Incorporated: Financials

Figure 58 MICRO-TECH (Nanjing) Co., Ltd.: Financials

Figure 59 ACE Medical Devices Pvt. Ltd.: Financials

글로벌 기관지내 초음파 생검 시장 – 2023-2030

Global Endobronchial Ultrasound Biopsy Market - 2023-2030